[Pubmed] Complement inhibitors for myasthenia gravis in adults
Posté : 08 juil. 2025 12:00
Cochrane Database Syst Rev. 2025 Jul 8;7:CD016098. doi: 10.1002/14651858.CD016098.
ABSTRACT
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of complement inhibitors for treating myasthenia gravis in adults compared with control treatment (placebo or standard care).
PMID:40626411 | DOI:10.1002/14651858.CD016098
Source: https://pubmed.ncbi.nlm.nih.gov/4062641 ... t9+e462414